Colorectal cancer (CRC) is the third most common cancer and the second most common cause of cancer deaths worldwide. In 2023, ...

NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical-stage biotechnology company pioneering innovative cancer and viral ...

Fintel reports that on January 7, 2025, RBC Capital initiated coverage of ICON Public Limited (NasdaqGS:ICLR) with a ...

MASH is a culmination of steatosis, inflammation, and fibrosis, and is also associated with comorbidities such as obesity and ...

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announces the company’s ...

Years of research have showed that pulse oximeters yield less accurate readings for people with darker skin tones, and now ...

The Barbara Ann Karmanos Cancer Institute welcomes José Larios, M.D., transplant hematologist. Dr. Larios is a member of the ...

Candid Therapeutics, Inc. ("Candid"), a clinical-stage biotechnology company focused on becoming the leader in advancing T-cell engagers for autoimmune and inflammatory diseases, announced today an ...

A critical incident is still in place as health services in Cornwall remain under immense pressure. The system critical ...

A top NHS doctor has warned the peak of the flu season is yet to come as hospitals in England grapple with high demand. It ...

A new study published in the journal Nature Medicine shows that specially trained AI program achieved an accuracy rate of more than 86% in identifying ovarian cancer by scanning ultrasounds, compared ...

Hospital has brought in emergency measures to deal with 'exceptionally high demand' - this is how it will impact patients and staff ...